Xuefei Wang

Xuefei Wang

Auto-generated profile, based on publicly available information

Xuefei Wang

Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
CMCongshun Ma
Congshun Ma
QXQianru Xiang
Qianru Xiang
GSGe Song
Ge Song
XWXuefei Wang
Xuefei Wang
Polycystic ovary syndrome (PCOS) is a reproductive endocrine disease, and results to opsomenorrhea or amenorrhea, hairy, acne, acanthosis, infertility, abortion. In the long term, PCOS may also increase the risk of endometrial cancer, diabetes, hypertension, dyslipidemia and other diseases. Till now there is no specific drug for PCOS due to the unclearness of the cause and pathogenesis, as current treatments for PCOS only target certain symptoms. Quercetin (QUR) is a flavonoid drug widely found in Chinese herbal medicines, fruits, leaves, vegetables, seeds and plants roots. Studies on other diseases have found that QUR has anti-oxidant, anti-inflammatory, anti-insulin resistance, anti-cancer and other effects. Some studies have shown that serum testosterone (T), luteinizing hormone (LH), the LH/follicule-stimulating hormone (FSH) ratio, fasting glucose, fasting insulin, HOMA-IR and lipid levels are reduced in PCOS patients with QUR treatment. However, the mechanisms of QUR in PCOS patients have not been completely elucidated. In this review, we retrospect the basic characteristics of QUR, and in vitro studies, animal experiments and clinical trials of QUR and plant extracts containing QUR in the treatment of PCOS. We also summarized the effects and mechanism of QUR in ovarian cells in vitro and PCOS model rats, the changes in relevant parameters after QUR administration in PCOS patients, and its potentially therapeutic applications.

1 January 2022 in Placenta
Verified
Journal Article
Closed access
HHHaoyue Hu
Haoyue Hu
WCWenqian Chen
Wenqian Chen
ZTZixin Tao
Zixin Tao
ZLZhiju Li
Zhiju Li
JHJiexing He
Jiexing He
MZMei Zhong
Mei Zhong

5 April 2025 in Journal of Autoimmunity
Verified
Journal Article
Closed access
HHHaoyue Hu
Haoyue Hu
YPYou Peng
You Peng
CWChi Chiu Wang
Chi Chiu Wang
JCJun Chen
Jun Chen
XYXiao Yu
Xiao Yu
MZMei Zhong
Mei Zhong

15 March 2022 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
HHHaoyue Hu
Haoyue Hu
JMJing Ma
Jing Ma
ZLZhiju Li
Zhiju Li
ZDZiling Ding
Ziling Ding
WCWenqian Chen
Wenqian Chen
MZMei Zhong
Mei Zhong

1 November 2020 in Life Sciences
Verified
Journal Article
Closed access
HHHaoyue Hu
Haoyue Hu
JJJiayi Jiang
Jiayi Jiang
QCQian Chen
Qian Chen
SWSongren Wei
Songren Wei
MLMian Liu
Mian Liu
MZMei Zhong
Mei Zhong